ATT-LD

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameATT-LD
Drug Alias Namelevodopa prodrug (Aposense)ATT-LD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAposense Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAposense Ltd
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A